Novasource

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Novasource

Property Description
Active Ingredients Complex matrix of Protein, Carbohydrates, Lipids, Vitamins, Minerals, and Electrolytes.
Form Ready-to-use liquid formula and Powder formula.
Pharmacological Class Medical Food / Specialized Nutritional Product.
Common Use Nutritional support for managing disease-related malnutrition or fluid restriction.
Origin Derived (Processed components from substrates like milk and corn).

What is the Core Classification of Novasource?

Novasource is defined as a Specialized Nutritional Product that falls within the classification of a Medical Food; it is not a traditional drug with a single INN (International Nonproprietary Name). A Medical Food is formulated for the dietary management of a disease or condition where distinctive nutritional requirements exist. This classification establishes Novasource as an Enteral Nutrition Preparation—a tool for clinical dietary support used under medical supervision, with its efficacy supported by pharmacological studies in complex patient care.

What is the Composition and Form of the Formula?

Novasource, manufactured by Nestlé Health Science, is a combination product that delivers a balanced matrix of essential macro- and micronutrients suspended in an aqueous vehicle. The core components include high-quality Protein sources, energy-dense Carbohydrates, and essential Lipids, along with a specialized profile of Vitamins and Minerals. Specific formulas, such as those intended for renal patients, are often calorically dense and contain a controlled amount of Electrolytes and Protein to meet unique metabolic needs. The product is primarily supplied as a ready-to-use liquid formula that may also be gluten-free or suitable for those with lactose intolerance.

What is the General Purpose of Enteral Nutrition?

The general purpose of this specialized enteral nutrition preparation is to ensure metabolic stability and prevent the physiological decline associated with severe nutritional deficits. Its primary function is the controlled, direct delivery of macro- and micronutrients to provide reliable energy provision and necessary hydration when the body is under stress. Specialized formulas are clinically recognized for supporting patients with specific disorders by tailoring nutrient content to the disease state. This preparation is critical in maintaining the patient's nutritional status during illness or recovery, particularly when fluid restriction is a clinical necessity.

What side effects are possible with Novasource?

Possible Side Effects and Safety Information

The safety profile for Novasource, classified as a Specialized Nutritional Product and Enteral Nutrition Preparation, is primarily characterized by physical tolerance issues and metabolic management considerations documented in official regulatory sources. The most common adverse reactions are related to the gastrointestinal system and are typically encountered during the initiation or rapid increase of feeding rate.

Officially Documented Adverse Reactions

The adverse effects are primarily grouped into two system-organ classes: Gastrointestinal Disorders and Metabolism and Nutrition Disorders.

Classification Examples of Documented Reactions
Common Diarrhea, nausea, vomiting
Uncommon Abdominal bloating, cramping, constipation

The most significant and serious adverse reaction officially associated with the initiation of aggressive nutritional support in malnourished patients is Refeeding Syndrome. This metabolic event involves potentially fatal shifts in fluid and electrolyte levels and requires careful clinical monitoring. Fluid and electrolyte imbalance itself is a key documented risk, especially in formulas designed for specific populations.

Safety Restrictions and Special Populations

Official labeling defines strict boundaries for the use of this product. Novasource is contraindicated in individuals diagnosed with galactosemia. Furthermore, the formula is strictly not for intravenous (parenteral) administration and is not suitable for patients with severe, non-functional gastrointestinal failure where absorption is impossible. For patients with renal impairment, specialized formulas necessitate close safety monitoring of fluid status and electrolyte levels, consistent with official regulatory documentation for this product class.

Overdose and Emergency Response

Overdose and when to seek help

The regulatory profile for Novasource, classified as a Specialized Nutritional Product or Medical Food, defines potential risks not by pharmacological toxicity, but by the consequences of over-administration or feed intolerance. The product must be administered only under the active and ongoing supervision of a physician.

Documented Overdose Manifestations

Documented over-administration may result in signs of feed intolerance, which include abdominal discomfort, bloating, diarrhoea, or vomiting. These symptoms are typically linked to rapid infusion rates or excessive volume, which can challenge the gastrointestinal system.

When Immediate Medical Help is Required

Immediate medical intervention is required when severe complications or emergencies arise from administration. The documented severe outcomes associated with complications of enteral feeding include aspiration pneumonia—a life-threatening respiratory risk—and severe metabolic upset, which may involve significant fluid or electrolyte imbalance. No specific antidote is applicable for this nutritional matrix; management is strictly supportive and procedural, involving medical assessment, and may include temporary cessation of the feed or rate adjustment as directed by a healthcare professional.

Therapeutic Uses of Novasource

What Novasource Treats: Main Uses and Benefits

Novasource is commonly used to address three main symptomatic and clinical domains, providing targeted clinical nutritional support where an underlying disease creates distinctive requirements. These products are intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements exist.

The formula is applied in the dietary management of Chronic Kidney Disease (CKD), Acute Kidney Injury (AKI), and disease-related malnutrition arising from hypercatabolic states or insufficient oral intake. In these situations, the formula provides supportive relief for symptom clusters that create noticeable physiological strain, such as unintentional weight loss and the decline of lean muscle mass, and can assist in the maintenance of metabolic stability.

“The specialized formulation is considered relevant for easing the distress associated with strict dietary restrictions in complex, chronic conditions.”

The product is further relevant for clinical settings that involve strict fluid restriction, where its high energy density in a minimal volume contributes to meeting energy and protein requirements without exceeding the safe fluid allowance, which may assist with maintaining functional stability.


Quick Fact: Relief for Nutritional Deficits
Novasource is commonly used to help manage the need for controlled intake of key minerals like potassium and phosphorus in patients with renal impairment.

Eligibility and Restrictions for Use

Novasource is a Specialized Nutritional Product intended for the dietary management of specific medical conditions and must be used strictly under medical supervision, as mandated by its regulatory classification.

Populations for Whom Use is Prohibited

Use of Novasource is contraindicated in specific populations based on metabolic and ingredient restrictions:

  • Individuals with the metabolic disorder galactosemia.
  • Patients with a known allergy to milk protein or soy protein, due to the formula's composition.
  • Any form of parenteral (intravenous) administration is strictly prohibited.

Age and Conditional Eligibility

Eligibility Category Regulatory Status
Targeted Use Primarily indicated for patients with Chronic Kidney Disease (CKD) on dialysis or Acute Kidney Injury (AKI), and those requiring fluid or electrolyte restriction.
Pediatric Restriction Not suitable for children below 4 years of age; established nutritional adequacy is primarily for adolescents and adults (age 13 or 14 and older).
Conditional Restriction Not recommended for patients with pre-dialysis renal failure who are actively managing a low protein diet.

The product is generally suitable for individuals managing lactose intolerance and those requiring a gluten-free diet, as specified in its official product labeling.

What should I know about interactions with other medicines?

Novasource, classified as a specialized nutritional product (Medical Food), exhibits documented interaction patterns that stem from its physicochemical composition as an enteral formula, not from typical drug metabolism pathways.

Administration Restrictions

A mandatory restriction explicitly prohibits the direct mixing of any medicinal product with the Novasource formula in the feeding tube or container. This is officially mandated to prevent physicochemical incompatibility, which can lead to coagulation, potential loss of drug potency, and the risk of feeding tube occlusion.


Documented Interaction Patterns

The formula's composition is associated with reduced systemic exposure for certain medicines. Phenytoin absorption is significantly reduced when co-administered, necessitating a mandatory feed-free period (timing separation) around the drug's delivery.

The multivalent cations (such as calcium, iron, and zinc) naturally present in the formula can bind to and reduce the bioavailability of substances like Fluoroquinolone Antibiotics through chelation.

Furthermore, the standardized Vitamin K content is documented to cause pharmacodynamic interference that reduces the clinical effect of Vitamin K Antagonists (e.g., Warfarin). The high caloric and carbohydrate load also establishes a potential for pharmacodynamic interaction with medicinal products used for blood glucose control or those that affect electrolyte balance.

Mechanism of Action

The active ingredient of Novasource is a selective inhibitor of the sodium-glucose co-transporter 2 (SGLT2) receptor. SGLT2 is predominantly located on the brush border of the proximal renal tubules and is responsible for the majority of glucose reabsorption from the glomerular filtrate back into the systemic circulation .

By binding to and inhibiting this receptor, Novasource reduces the tubular reabsorption of filtered glucose. This mechanistic action decreases the renal threshold for glucose, resulting in a mechanistic cascade of increased urinary glucose excretion (UGE).

This increase in UGE creates a localized osmotic gradient within the renal tubule, leading to osmotic diuresis and subsequent fluid loss. Furthermore, the active ingredient exhibits greater selectivity for SGLT2 over SGLT1, minimizing off-target physiological effects.

Dosage and Administration Information

How to Use Novasource

Novasource is a Specialized Nutritional Product intended for dietary management under medical guidance, and its administration follows a specific protocol. Its usage is focused strictly on nutritional delivery, distinct from standard drug prescribing.


Administration and Dosage Principles

Administration Route

The formula is approved for two primary routes of entry: oral supplementation (consumed by mouth) and enteral feeding via a tube (e.g., nasogastric, gastrostomy). The product is not intended for intravenous or parenteral administration under any circumstances.

Dosing and Frequency

The volume of Novasource administered is highly individualized and determined by a healthcare professional based on the patient's specific daily energy and protein requirements. As a general usage pattern, the formula may be consumed daily, ranging from one to two units per day when used as a supplement, up to five units per day when serving as a sole source of nutrition. For continuous enteral delivery, administration is initiated at a low, gradually increasing rate following established clinical protocols.


Special Administration Requirements

Preparation and Handling

Prior to administration, the ready-to-use liquid formula must be shaken well and is generally served chilled for oral intake. When used in a tube feeding setup, it is instructed not to add or mix medications or other solutions directly into the Novasource container, as this may compromise the product's nutritional consistency and stability.

Population Constraints

The formula's high caloric density (2.0 kcal/mL) is specifically utilized for patients requiring fluid restriction, ensuring nutritional goals can be met with minimal volume. Use is restricted by age; the formula is not suitable for administration to children under 4 years of age.

Recent Clinical Evidence

Research evidence / Overview of Studies for Novasource

The research base for specialized nutritional preparations was examined to explore how these formulas was studied for patients who have difficulty meeting their nutrient requirements due to complex medical conditions. This body of research includes various study designs, such as randomized controlled trials (RCTs), systematic reviews, and observational studies.


Evidence for Use in Managing Kidney-Related Nutritional Needs

This section will summarize the types of Randomized Controlled Trials (RCTs) and observational studies that have researched specialized nutritional support for patients with Chronic Kidney Disease (CKD) and Acute Kidney Injury (AKI), focusing on the specific biochemical and anthropometric outcomes measured in these groups.

Research examined renal-specific nutritional formulas that was evaluated in patient populations with advanced CKD, including those receiving maintenance dialysis. Studies primarily monitored outcomes related to systemic or functional imbalance, such as fluid balance and specific biochemical markers, including serum potassium and phosphorus levels. Studies monitored measurements related to the formulas' use and the relationship to meeting nutritional requirements within controlled fluid volumes.

What remains uncertain: The long-term effects for renal function progression are not fully established. Researchers have noted that studies often rely on surrogate nutritional markers (like body weight changes) rather than long-term clinical outcomes. Comparative evidence, such as head-to-head RCTs against a neutral comparator across all stages of CKD, is lacking.


Evidence for Use in Managing Disease-Related Malnutrition

This segment will present an overview of the Systematic Reviews and clinical trials that researched specialized nutritional preparations in patients with disease-related malnutrition and those in hypercatabolic states, describing the measures used to track nutritional status and functional metrics.

Trials consistently reported data showing patterns related to measurements of energy and protein intake in patients receiving specialized nutritional support. Research highlights changes monitored during the study period, with some findings describing patterns related to measurements of body composition and weight over intermediate follow-up. However, when research monitored outcomes related to episodic or acute changes (such as mortality or readmission rates) across the broad, mixed populations, the findings were mixed due to high methodological variability.


Research Gaps and Areas of Uncertainty

This final section will synthesize the major limitations identified in the evidence base. Findings were mixed when attempting to track data patterns related to hard clinical outcomes across different patient groups because of high methodological variability between studies. Furthermore, sample sizes were modest in some pivotal trials, and the reliance on short-term nutritional markers rather than consistent tracking of functional outcomes means the broader clinical picture is not always fully characterized.

Key Studies & References

  1. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update
  2. ESPEN practical guideline: Clinical nutrition and hydration in geriatrics (2022)

Frequently Asked Questions (FAQ)

Common questions about Novasource (FAQ)

Q: Is Novasource a prescription-only medicine?

Novasource is classified by regulatory bodies as a Specialized Nutritional Product, also known as a Medical Food. While it is not a traditional prescription drug, official labeling mandates that it be used under the supervision of a healthcare professional due to its specific dietary management purpose.


Q: How is Novasource different from other similar products I see advertised?

Official documents describe Novasource as a specialized nutritional product specifically formulated to meet distinctive nutritional requirements. Products like Novasource Renal are designed to be calorically dense (e.g., 2.0 kcal/mL) and have an adapted electrolyte content, which allows healthcare professionals to address complex needs like fluid restriction.


Q: Does Novasource contain any common allergens, like gluten or soy?

According to the official product information, specific Novasource formulas are typically gluten-free and suitable for those with lactose intolerance. However, the formula contains both milk and soy protein, which are listed as contraindications for individuals with known allergies to those components.


Q: Can Novasource be taken by people with kidney issues?

Specific specialized formulas like Novasource Renal are described in official documents as being indicated for the dietary management of patients with Chronic Kidney Disease (CKD) on dialysis or Acute Kidney Injury (AKI). However, its use is contra-indicated for patients with severe renal impairment who are on a low-protein diet and not yet receiving dialysis.


Q: Are there different strengths or types of Novasource?

The Novasource portfolio includes different product types, each formulated to address specific nutritional needs. Examples include formulas designed for general nutrition support and specialized formulas like Novasource Renal, which is adapted with specific caloric density and electrolyte content, all typically available as a ready-to-use liquid.


Q: Can Novasource cause changes in my sleep patterns?

The common adverse reactions documented in official sources are primarily related to gastrointestinal issues (such as diarrhea and nausea) and metabolism and nutrition disorders. Changes in sleep patterns are not typically listed among the officially common or uncommon side effects.


Q: Is Novasource addictive or habit-forming?

Novasource is officially classified as a Specialized Nutritional Product (Medical Food). It is composed of a complex matrix of essential nutrients, not a single drug ingredient, and is therefore not associated with the pharmacological effects that typically lead to addiction or habit formation.


Q: Do I need to take Novasource with food or on an empty stomach?

Novasource is used either as an oral nutritional supplement or as a sole source of nutrition via enteral tube feeding. The schedule for consumption is part of the specific nutritional plan developed by a healthcare professional and is typically not governed by a mandatory timing relative to food intake.


Q: Is there a generic version of Novasource available?

As a Specialized Nutritional Product formulated with a complex matrix of ingredients, Novasource is a proprietary formula. It does not have a single active drug ingredient and is not assigned a generic name (International Nonproprietary Name) in the way a traditional pharmaceutical drug is.


Q: Does research show Novasource helps everyone who takes it?

Official research summaries and systematic reviews indicate that while the product consistently shows patterns related to meeting energy and protein intake goals, findings on broader, long-term clinical outcomes across different patient groups have been mixed. Results often vary based on patient population and study design.


Q: Can Novasource affect my ability to drive or operate machinery?

Official documentation does not specifically caution against driving or operating machinery. The officially documented common adverse reactions are typically limited to gastrointestinal disorders and metabolism issues, which are not typically listed as affecting cognitive or physical abilities related to driving. Patients should follow medical guidance regarding any effects they experience.


Q: Are there any specific laboratory tests required before starting Novasource?

Official labeling for this class of specialized product mandates close safety monitoring of a patient's fluid status and electrolyte levels, particularly in patients with kidney impairment. This indicates that laboratory testing is commonly part of the overall clinical monitoring process before and during the product's use, as determined by a healthcare professional.


Q: Is the core research on Novasource published and peer-reviewed?

Yes, the research base supporting the use of specialized nutritional preparations includes evidence from various study designs, such as randomized controlled trials (RCTs) and systematic reviews. This body of evidence constitutes the published, peer-reviewed support for its use.


Q: Why does the official leaflet list so many possible side effects for Novasource?

Regulatory requirements from bodies like the FDA mandate that the manufacturer's labeling includes all adverse reactions that have been officially documented during clinical trials and post-market use. This comprehensive listing is standard practice to ensure healthcare providers and patients are fully informed of the product's complete safety profile.


Q: What do the official documents say about Novasource use during pregnancy?

As a Specialized Nutritional Product, Novasource is typically not assigned a standard drug pregnancy category. Nutritional support during pregnancy is determined by a specialized medical risk/benefit assessment that is conducted by a healthcare professional based on the individual patient's nutritional needs.


Q: Can people with liver problems safely take Novasource?

Impaired liver function is not listed as a specific contraindication in official documents. However, because Novasource is a Medical Food used in complex conditions, patients with liver issues may require specific monitoring of their nutritional status and metabolic stability under the guidance of a healthcare professional.


Q: What is the difference between the brand name and the generic equivalent of Novasource?

Since Novasource is not a single chemical entity (drug) but a complex, proprietary Specialized Nutritional Product, there is no single generic drug equivalent that can be substituted based on a drug name alone.


Q: Does Novasource cause weight gain or loss?

Official studies on the formula monitored measurements related to body composition and weight over time. The product is used to ensure metabolic stability and prevent decline due to malnutrition, and managing weight changes is a key goal of specialized nutritional support.


Q: Do regulatory bodies classify Novasource as high-risk or low-risk?

Novasource is classified as a Specialized Nutritional Product (Medical Food), which is distinct from a high-risk pharmaceutical drug. However, its use carries specific, officially documented risks, such as the potential for Refeeding Syndrome and electrolyte imbalance, which necessitate use under medical supervision.


Q: What should I do if I experience an unexpected effect while on Novasource?

Official regulatory guidance requires that patients and healthcare providers report any unexpected or serious adverse effects to the regulatory agency (such as the FDA MedWatch program) or the manufacturer. Any unexpected effects should be discussed with the supervising healthcare professional for appropriate direction and evaluation.


Q: Are there any specific foods or drinks to avoid while taking Novasource?

Official documentation strictly prohibits the direct mixing of any medicinal product into the Novasource formula. Due to the product's high caloric and carbohydrate load, it establishes a potential for interaction with medicines that affect blood glucose control, requiring careful management of a patient's overall diet.


Q: What happens if I accidentally take more Novasource than prescribed?

The most significant documented safety risk associated with the aggressive initiation of nutritional support is Refeeding Syndrome, which involves potentially fatal shifts in fluid and electrolytes. Official documentation indicates that volumes significantly exceeding the prescribed amount should be brought to the attention of a healthcare professional promptly, due to the documented safety risks associated with fluid and electrolyte imbalance.


Q: Can I use Novasource if I am also taking medication for blood pressure?

The official product information cautions that the formula's composition establishes a potential for interaction with medicines that affect blood glucose control or electrolyte balance. Therefore, concomitant use with medications that affect these systems, such as certain blood pressure or diuretic medications, requires clinical monitoring.


Q: Does Novasource affect blood sugar levels?

Yes, because the formula contains a significant carbohydrate load, it establishes a potential for pharmacodynamic interaction with medicinal products used for blood glucose control. Close monitoring of blood sugar levels is a necessary part of the management plan.

How should Novasource be stored and disposed of?

Storage and Stability Conditions

Unopened containers of Novasource must be stored at room temperature in a cool and dry place. It is mandatory to not freeze the liquid formula, as this may compromise its stability and integrity. The product must be shaken well before opening and should not be used past the expiration date printed on the container.

Handling and In-Use Limits

Once a container is opened, any unused portion must be immediately refrigerated and tightly covered to prevent contamination. The formula must then be consumed or discarded within 24 hours. For tube feeding administration, the hang time for the formula in an open system should generally be limited to mathbf8 hours at room temperature. Always store the product out of the sight and reach of children.

Disposal Requirements

Expired or unused portions of Novasource must be discarded. Disposal of the product and its packaging must be completed in accordance with local regulations for non-hazardous nutritional supplements to ensure proper handling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Novasource found in:

A-Z Index: